首页 > 最新文献

Neonatology最新文献

英文 中文
Transfusion histories of neonates who developed severe retinopathy of prematurity. 发生严重早产儿视网膜病变的新生儿输血史。
IF 3 Pub Date : 2026-03-23 DOI: 10.1159/000551673
Bailey B Zeiler, M Elizabeth Hartnett, Joel L Addams, Elizabeth F Stone, Sarah J Ilstrup, Timothy M Bahr, Robin K Ohls, Robert D Christensen

Introduction: The recent BORN study suggests the incidence of retinopathy of prematurity (ROP) might be significantly reduced by transfusing extremely low gestational age neonates (ELGANs) with red blood cells (RBCs) from term umbilical cord blood. We are uncertain what proportion of infants with severe ROP had no RBC transfusions and thus would not benefit from changing transfusion practice.

Methods: We created detailed transfusion histories of all infants in our health system (2021 - 2024) who developed severe ROP.

Results: Severe (stage ≥3) ROP was diagnosed in 34 infants; 32 of these had received 1-18 RBC transfusions. Eleven also received 1-16 platelet transfusions. Two received no transfusions.

Conclusion: A small minority of infants with severe ROP were never transfused, thus changing transfusion practice would not likely prevent all cases. However, the great majority had multiple RBC transfusions and thus might benefit from cord blood RBC transfusions.

导语:最近的BORN研究表明,向极低胎龄新生儿(elgan)输注足月脐带血中的红细胞(rbc)可能会显著降低早产儿视网膜病变(ROP)的发生率。我们不确定有多少比例的严重ROP婴儿没有红细胞输血,因此不会从改变输血做法中获益。方法:我们创建了我们卫生系统(2021 - 2024)中发生严重ROP的所有婴儿的详细输血史。结果:34例患儿诊断为重度(≥3期)ROP;其中32例接受了1-18次红细胞输注。其中11例接受1-16次血小板输注。其中两人没有接受输血。结论:少数严重ROP患儿从未输血,因此改变输血做法不可能预防所有病例。然而,绝大多数有多次红细胞输注,因此可能受益于脐带血红细胞输注。
{"title":"Transfusion histories of neonates who developed severe retinopathy of prematurity.","authors":"Bailey B Zeiler, M Elizabeth Hartnett, Joel L Addams, Elizabeth F Stone, Sarah J Ilstrup, Timothy M Bahr, Robin K Ohls, Robert D Christensen","doi":"10.1159/000551673","DOIUrl":"https://doi.org/10.1159/000551673","url":null,"abstract":"<p><strong>Introduction: </strong>The recent BORN study suggests the incidence of retinopathy of prematurity (ROP) might be significantly reduced by transfusing extremely low gestational age neonates (ELGANs) with red blood cells (RBCs) from term umbilical cord blood. We are uncertain what proportion of infants with severe ROP had no RBC transfusions and thus would not benefit from changing transfusion practice.</p><p><strong>Methods: </strong>We created detailed transfusion histories of all infants in our health system (2021 - 2024) who developed severe ROP.</p><p><strong>Results: </strong>Severe (stage ≥3) ROP was diagnosed in 34 infants; 32 of these had received 1-18 RBC transfusions. Eleven also received 1-16 platelet transfusions. Two received no transfusions.</p><p><strong>Conclusion: </strong>A small minority of infants with severe ROP were never transfused, thus changing transfusion practice would not likely prevent all cases. However, the great majority had multiple RBC transfusions and thus might benefit from cord blood RBC transfusions.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-9"},"PeriodicalIF":3.0,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research at the Paris Foundling Hospitals. Part 2: After the Revolution. 巴黎育婴堂医院的研究第二部分:革命后。
IF 3 Pub Date : 2026-03-23 DOI: 10.1159/000551576
Michael Obladen

Background: We know little how neonatal research changed at the Paris Foundling Hospital following the Revolution.

Summary: The number of unwanted children rose and 5,392 infants were admitted in 1826 - a quarter of all infants born in Paris. 26% of them died in the infirmary before transport. The infants' appalling mortality was associated with artificial nutrition, and transfer to mercenary nurses in the countryside was organized. In the 1830s, sedentary nurses began to run short, and nearly all babies were fed artificially at some time. François Chaussier was director at the Maternity from 1804. He developed instruments to resuscitate newborns: mask-and-bag ventilation, silver endotracheal tubes, and oxygen tanks. He classified congenital malformations and described osteogenesis imperfecta. Marie-Louise Lachappelle trained midwives in forceps deliveries and use of endotracheal intubation of newborns. Other researchers at the foundling hospital included Antoine Dugès, Jacques-François Baron, Gilbert Breschet, Louis Véron, Johann Heyfelder, Prosper-Sylvain Denis and Charles Billard. The latter investigated neonatal cry in 1827 and associated expiratory grunting with poor prognosis in prematures. His Treatise on Diseases of the Newborn, based on many autopsies and meticulous clinical records, remained neonatology standard for a century. It described peritonitis, megacolon, intestinal hemorrhage, pertussis, spina bifida, patent ductus, single ventricle, and various forms of tuberculosis.

Key messages: Physicians were permanently employed from 1821, their research developed from autopsies. The fusion of Medicine and Surgery into a single faculty moved obstetrics (and thus newborn care) from the barbers' domain to research-oriented science.

背景:我们对大革命后巴黎育婴堂医院新生儿研究的变化知之甚少。概要:被遗弃的儿童数量上升,1826年有5392名婴儿被收容,占巴黎出生婴儿总数的四分之一,其中26%在运送前死于医务室。婴儿惊人的死亡率与人工营养有关,并被组织转移到农村的雇佣兵护士那里。在19世纪30年代,久坐不动的护士开始短缺,几乎所有的婴儿在一段时间内都是人工喂养的。francois Chaussier从1804年起担任产科医院的主任。他发明了使新生儿复苏的仪器:面罩袋通气、银气管内管和氧气罐。他对先天性畸形进行了分类,并描述了成骨不完全性。玛丽-路易斯·拉卡佩尔对助产士进行了产钳分娩和新生儿气管插管使用方面的培训。育婴堂的其他研究人员包括Antoine dug, jacques - franois Baron, Gilbert brechet, Louis v, Johann Heyfelder, Prosper-Sylvain Denis和Charles Billard。后者于1827年调查了新生儿啼哭和与早产儿预后不良相关的呼气咕噜声。他的《新生儿疾病论》以大量的尸检和细致的临床记录为基础,一个世纪以来一直是新生儿学的标准。它描述了腹膜炎、巨结肠、肠出血、百日咳、脊柱裂、导管未闭、单心室和各种形式的肺结核。关键信息:从1821年开始,医生被永久聘用,他们的研究是从尸体解剖中发展起来的。医学和外科的合并使产科(以及新生儿护理)从理发师的领域变成了以研究为导向的科学。
{"title":"Research at the Paris Foundling Hospitals. Part 2: After the Revolution.","authors":"Michael Obladen","doi":"10.1159/000551576","DOIUrl":"https://doi.org/10.1159/000551576","url":null,"abstract":"<p><strong>Background: </strong>We know little how neonatal research changed at the Paris Foundling Hospital following the Revolution.</p><p><strong>Summary: </strong>The number of unwanted children rose and 5,392 infants were admitted in 1826 - a quarter of all infants born in Paris. 26% of them died in the infirmary before transport. The infants' appalling mortality was associated with artificial nutrition, and transfer to mercenary nurses in the countryside was organized. In the 1830s, sedentary nurses began to run short, and nearly all babies were fed artificially at some time. François Chaussier was director at the Maternity from 1804. He developed instruments to resuscitate newborns: mask-and-bag ventilation, silver endotracheal tubes, and oxygen tanks. He classified congenital malformations and described osteogenesis imperfecta. Marie-Louise Lachappelle trained midwives in forceps deliveries and use of endotracheal intubation of newborns. Other researchers at the foundling hospital included Antoine Dugès, Jacques-François Baron, Gilbert Breschet, Louis Véron, Johann Heyfelder, Prosper-Sylvain Denis and Charles Billard. The latter investigated neonatal cry in 1827 and associated expiratory grunting with poor prognosis in prematures. His Treatise on Diseases of the Newborn, based on many autopsies and meticulous clinical records, remained neonatology standard for a century. It described peritonitis, megacolon, intestinal hemorrhage, pertussis, spina bifida, patent ductus, single ventricle, and various forms of tuberculosis.</p><p><strong>Key messages: </strong>Physicians were permanently employed from 1821, their research developed from autopsies. The fusion of Medicine and Surgery into a single faculty moved obstetrics (and thus newborn care) from the barbers' domain to research-oriented science.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-16"},"PeriodicalIF":3.0,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 3 Pub Date : 2026-03-18 DOI: 10.1159/000551110

The article "Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures" [Neonatology. 2025; https://doi.org/10.1159/000549690] by Rondagh et al. was published with the wrong open access license. The correct license of the article is CC-BY.The original article has been updated.

文章“利多卡因作为附加治疗(波幅综合)脑电图证实的新生儿癫痫发作前后的癫痫发作负担”[新生儿学]。2025年;https://doi.org/10.1159/000549690] by Rondagh et al.使用了错误的开放获取许可。文章的正确许可是CC-BY。原文已更新。
{"title":"Erratum.","authors":"","doi":"10.1159/000551110","DOIUrl":"10.1159/000551110","url":null,"abstract":"<p><p>The article \"Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures\" [Neonatology. 2025; https://doi.org/10.1159/000549690] by Rondagh et al. was published with the wrong open access license. The correct license of the article is CC-BY.The original article has been updated.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1"},"PeriodicalIF":3.0,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147483085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2026. 欧洲呼吸窘迫综合征管理共识指南- 2026。
IF 3 Pub Date : 2026-03-16 DOI: 10.1159/000551577
Eric S Shinwell, Roger F Soll
{"title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2026.","authors":"Eric S Shinwell, Roger F Soll","doi":"10.1159/000551577","DOIUrl":"https://doi.org/10.1159/000551577","url":null,"abstract":"","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147470666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Variants Associated with Persistent Pulmonary Hypertension of Newborn: A Systematic Review. 遗传变异与新生儿持续性肺动脉高压相关:一项系统综述。
IF 3 Pub Date : 2026-03-13 DOI: 10.1159/000550289
Srinivasan Mani, Seth I Berger

Background: Persistent pulmonary hypertension of newborn (PPHN) occurs due to the impairment in the expected fall in pulmonary vascular resistance during the fetal to neonatal circulatory transition, with a prevalence of 1.9 per 1000 live births, and a significant mortality rate of 4-33%.

Objective: We aimed to systematically review the genetic variants associated with PPHN in term and late preterm infants without a known genetic syndrome.

Methods: In February 2025, the MEDLINE OVID, SCOPUS, and COCHRANE databases were searched for eligible studies without publication date restriction. Our review included cohort studies, case-control studies, and case series that examined the association of PPHN and genetic variants in term and late preterm infants. We extracted data regarding the methodology, participant characteristics, and outcome measures.

Results: We included nine studies (7 case-control studies and 2 cohort studies) that enrolled 1,494 participants. The risk of bias assessment using the Quality of Genetic Association Studies tool showed that 91% of the studies were of moderate or good quality. Our review found reports of positive associations between specific genetic variants in genes such as CPS1, CRHR1, NOTCH3, EDN1, EPAS1, WWC2, ABCA3, RFX3, EP300, GNA11, PKLR, SLC2A1, BMPR2, and EGLN1. One study reported no association between an ACE gene variant and PPHN.

Conclusion: Studies of common genetic variants associated with an increased risk of PPHN in term and late preterm infants are limited, based on small cohorts and frequently focused on small sets of candidate genes, yielding inconsistent results across studies.

背景:新生儿持续性肺动脉高压(PPHN)是由于胎儿到新生儿循环过渡期间肺血管阻力预期下降受损而发生的,患病率为每1000例活产1.9例,死亡率为4-33%。目的:我们旨在系统地回顾无已知遗传综合征的足月和晚期早产儿与PPHN相关的遗传变异。方法:于2025年2月在MEDLINE OVID、SCOPUS和COCHRANE数据库中检索无发表日期限制的符合条件的研究。我们的综述包括队列研究、病例对照研究和病例系列研究,这些研究检查了足月和晚期早产儿PPHN与遗传变异的关系。我们提取了有关方法、参与者特征和结果测量的数据。结果:我们纳入了9项研究(7项病例对照研究和2项队列研究),共纳入1494名受试者。使用遗传关联研究质量工具进行偏倚风险评估显示,91%的研究质量为中等或良好。我们的综述发现,CPS1、CRHR1、NOTCH3、EDN1、EPAS1、WWC2、ABCA3、RFX3、EP300、GNA11、plklr、SLC2A1、BMPR2和EGLN1等基因的特定遗传变异之间存在正相关。一项研究报告ACE基因变异与PPHN之间没有关联。结论:研究与足月和晚期早产儿PPHN风险增加相关的常见遗传变异是有限的,基于小队列,并且经常集中在小组候选基因上,在研究中产生不一致的结果。
{"title":"Genetic Variants Associated with Persistent Pulmonary Hypertension of Newborn: A Systematic Review.","authors":"Srinivasan Mani, Seth I Berger","doi":"10.1159/000550289","DOIUrl":"https://doi.org/10.1159/000550289","url":null,"abstract":"<p><strong>Background: </strong>Persistent pulmonary hypertension of newborn (PPHN) occurs due to the impairment in the expected fall in pulmonary vascular resistance during the fetal to neonatal circulatory transition, with a prevalence of 1.9 per 1000 live births, and a significant mortality rate of 4-33%.</p><p><strong>Objective: </strong>We aimed to systematically review the genetic variants associated with PPHN in term and late preterm infants without a known genetic syndrome.</p><p><strong>Methods: </strong>In February 2025, the MEDLINE OVID, SCOPUS, and COCHRANE databases were searched for eligible studies without publication date restriction. Our review included cohort studies, case-control studies, and case series that examined the association of PPHN and genetic variants in term and late preterm infants. We extracted data regarding the methodology, participant characteristics, and outcome measures.</p><p><strong>Results: </strong>We included nine studies (7 case-control studies and 2 cohort studies) that enrolled 1,494 participants. The risk of bias assessment using the Quality of Genetic Association Studies tool showed that 91% of the studies were of moderate or good quality. Our review found reports of positive associations between specific genetic variants in genes such as CPS1, CRHR1, NOTCH3, EDN1, EPAS1, WWC2, ABCA3, RFX3, EP300, GNA11, PKLR, SLC2A1, BMPR2, and EGLN1. One study reported no association between an ACE gene variant and PPHN.</p><p><strong>Conclusion: </strong>Studies of common genetic variants associated with an increased risk of PPHN in term and late preterm infants are limited, based on small cohorts and frequently focused on small sets of candidate genes, yielding inconsistent results across studies.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-22"},"PeriodicalIF":3.0,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147461509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotics for preventing Necrotising Enterocolitis: What do we do if Randomised Control Trials cannot give us the answer? 益生菌预防坏死性小肠结肠炎:如果随机对照试验不能给我们答案,我们该怎么办?
IF 3 Pub Date : 2026-03-12 DOI: 10.1159/000551482
Ian Jones
{"title":"Probiotics for preventing Necrotising Enterocolitis: What do we do if Randomised Control Trials cannot give us the answer?","authors":"Ian Jones","doi":"10.1159/000551482","DOIUrl":"https://doi.org/10.1159/000551482","url":null,"abstract":"","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147446665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 3 Pub Date : 2026-03-11 DOI: 10.1159/000551023

The article "Deferred Cord Clamping in Very Preterm Triplets and Outcomes: A Retrospective Cohort Study" [Neonatology. 2025; https://doi.org/10.1159/000550056] by Shah et al. was published with the wrong open access license. The correct license of the article is CC-BY.The original article has been corrected.

文章“延迟脐带夹紧在非常早产三胞胎和结果:回顾性队列研究”[新生儿学]。2025年;Shah等人的https://doi.org/10.1159/000550056]是用错误的开放获取许可发表的。文章的正确许可是CC-BY。原文已被更正。
{"title":"Erratum.","authors":"","doi":"10.1159/000551023","DOIUrl":"https://doi.org/10.1159/000551023","url":null,"abstract":"<p><p>The article \"Deferred Cord Clamping in Very Preterm Triplets and Outcomes: A Retrospective Cohort Study\" [Neonatology. 2025; https://doi.org/10.1159/000550056] by Shah et al. was published with the wrong open access license. The correct license of the article is CC-BY.The original article has been corrected.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1"},"PeriodicalIF":3.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147437610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing diagnostic accuracy of a handheld point-of-care device for quantifying neonatal bilirubin levels: the BEAT jaundice @home study. 评估用于量化新生儿胆红素水平的手持式护理点设备的诊断准确性:BEAT黄疸在家研究。
IF 3 Pub Date : 2026-03-11 DOI: 10.1159/000551324
Lauren E H Westenberg, Jasper V Been, Andrei Tintu, Jolande Y Vis, Helene A Bouma, Daan Nieboer, Peter H Dijk, Henk Groen, Marten J Poley, Erwin Ista, Eric A P Steegers, Irwin K M Reiss, Berthe A M van der Geest, Christian V Hulzebos

Introduction The Bilistick is a handheld point-of-care device for measuring total bilirubin levels in small blood volumes. We assessed its diagnostic accuracy and user convenience in near-term neonates cared for at home. Methods A prospective cohort study was conducted in nine Dutch community midwifery practices. Neonates ≥35 weeks' gestation were eligible if they were at home between postnatal days 2-8 and had not received phototherapy. A Bilistick version 2.0 was used in parallel to laboratory-based bilirubin (LBB) quantification when significant visible jaundice was observed or the transcutaneous bilirubin reading was elevated. Results 2314 neonates were included in the study, with 423 blood samples analyzed across 13 laboratories. On 203 occasions, the Bilistick was not used. Among the remaining 220 Bilistick readings, 104 failed, and two lacked corresponding LBB results. A Bland-Altman plot of 114 paired measurements of Bilistick and LBB showed a mean difference of +9.7 µmol/L (0.57 mg/dL) with corresponding 95% limits of agreement of -179.7 to +199.2 µmol/L (-10.5 to 11.7 mg/dL). The positive predictive value of a Bilistick reading for having a TSB level above the phototherapy threshold was 36.4%. The negative predictive value was 90.1%, sensitivity 60% and specificity 77.6%. Hemolysis (24%) contributed to overestimations by the Bilistick. Community midwives expressed multiple barriers related to user convenience. Conclusion Diagnostic accuracy of the Bilistick when used in the home setting was limited. Its use was further hindered by a significant proportion of failed readings and low user-convenience when operated by midwives.

Bilistick是一种手持式即时护理设备,用于测量小血容量中总胆红素水平。我们评估了其诊断的准确性和近期在家护理新生儿的用户便利性。方法对荷兰9个社区助产机构进行前瞻性队列研究。妊娠≥35周的新生儿如果在出生后2-8天期间在家且未接受光疗,则符合条件。当观察到明显的可见黄疸或经皮胆红素读数升高时,Bilistick 2.0版本与实验室胆红素(LBB)定量同时使用。结果2314名新生儿纳入研究,分析了13个实验室的423份血液样本。有203次没有使用Bilistick。在剩余的220个Bilistick读数中,104个不合格,两个缺乏相应的LBB结果。Bland-Altman图显示,Bilistick和LBB的114个成对测量值的平均差异为+9.7µmol/L (0.57 mg/dL),相应的95%一致性限为-179.7 ~ +199.2µmol/L (-10.5 ~ 11.7 mg/dL)。Bilistick读数对TSB水平高于光疗阈值的阳性预测值为36.4%。阴性预测值为90.1%,敏感性60%,特异性77.6%。溶血(24%)导致了Bilistick的高估。社区助产士表达了与用户便利性相关的多重障碍。结论Bilistick在家庭环境下的诊断准确性有限。它的使用进一步受到很大比例的读数不合格和助产士操作时用户便利性低的阻碍。
{"title":"Assessing diagnostic accuracy of a handheld point-of-care device for quantifying neonatal bilirubin levels: the BEAT jaundice @home study.","authors":"Lauren E H Westenberg, Jasper V Been, Andrei Tintu, Jolande Y Vis, Helene A Bouma, Daan Nieboer, Peter H Dijk, Henk Groen, Marten J Poley, Erwin Ista, Eric A P Steegers, Irwin K M Reiss, Berthe A M van der Geest, Christian V Hulzebos","doi":"10.1159/000551324","DOIUrl":"https://doi.org/10.1159/000551324","url":null,"abstract":"<p><p>Introduction The Bilistick is a handheld point-of-care device for measuring total bilirubin levels in small blood volumes. We assessed its diagnostic accuracy and user convenience in near-term neonates cared for at home. Methods A prospective cohort study was conducted in nine Dutch community midwifery practices. Neonates ≥35 weeks' gestation were eligible if they were at home between postnatal days 2-8 and had not received phototherapy. A Bilistick version 2.0 was used in parallel to laboratory-based bilirubin (LBB) quantification when significant visible jaundice was observed or the transcutaneous bilirubin reading was elevated. Results 2314 neonates were included in the study, with 423 blood samples analyzed across 13 laboratories. On 203 occasions, the Bilistick was not used. Among the remaining 220 Bilistick readings, 104 failed, and two lacked corresponding LBB results. A Bland-Altman plot of 114 paired measurements of Bilistick and LBB showed a mean difference of +9.7 µmol/L (0.57 mg/dL) with corresponding 95% limits of agreement of -179.7 to +199.2 µmol/L (-10.5 to 11.7 mg/dL). The positive predictive value of a Bilistick reading for having a TSB level above the phototherapy threshold was 36.4%. The negative predictive value was 90.1%, sensitivity 60% and specificity 77.6%. Hemolysis (24%) contributed to overestimations by the Bilistick. Community midwives expressed multiple barriers related to user convenience. Conclusion Diagnostic accuracy of the Bilistick when used in the home setting was limited. Its use was further hindered by a significant proportion of failed readings and low user-convenience when operated by midwives.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-17"},"PeriodicalIF":3.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare professionals' availability for management of preterm neonates < 29 weeks' gestation in 12 iNeo neonatal networks. 医疗professionals&apos;29周及以上早产儿管理的可得性;12个iNeo新生儿网络的妊娠情况。
IF 3 Pub Date : 2026-03-09 DOI: 10.1159/000551461
Gil Klinger, Maher Shahroor, Dan Felder, Kei Lui, Annalisa Mori, Mark Adams, Laura San Feliciano, Tetsuya Isayama, Valerie Biran, Dirk Bassler, Brian Reichman, Aleksandra Skubisz, Malcolm Battin, Liisa Lehtonen, Kjell Helenius, Maximo Vento, Satoshi Kusuda, Mikael Norman, Renato S Procianoy, Neha Goswami, Prakesh S Shah

Introduction: Availability and expertise of healthcare professional are essential for the quality of care of preterm infants. Objective was to survey different healthcare professionals' availability for management of preterm neonates <29 weeks' gestation among neonatal intensive care units (NICU) of 12 population-based neonatal networks.

Methods: Questionnaires were distributed to 608 NICU participating in the International Network for Evaluating Outcomes in Neonates (iNeo). Networks included: Australia/New-Zealand (n= 30), Brazil (n=20), Canada (n=32), Finland (n=5), France (n=70), Israel (n=26), Japan (n=292), Poland (n=56), Spain (n=55), Sweden (n=9), Switzerland (n=9) and Tuscany (n=4). Questions focused on availability of physicians, nurses and additional healthcare professionals in 2023.

Results: A total of 382 (63%) NICU responded. The 24/7 availability of healthcare professionals varied within and between networks and overall was reported to be 66% for neonatologists, 55% for neonatal fellows, 62% for pediatric residents and 55% for nurse practitioners. Nurse-to-patient ratios were most commonly 1:1 for complex critical care infants (53%) and 1:2 for intensive care infants (48%). Low 24/7 availability was reported for respiratory therapists and pharmacists.

Conclusions: Marked variations exist in health care professionals' availability, which might be associated with NICU organization and management of infants <29 weeks' gestation. While majority of NICU have reported 24/7 availability of neonatologists, the availability of other healthcare professionals was inconsistent. Nurse-to-patient ratio has improved. Further evaluation is needed to understand how these variations are associated with outcomes of extremely preterm infants and to optimize resource utilization.

简介:医疗保健专业人员的可用性和专业知识对早产儿的护理质量至关重要。目的是调查不同医疗保健专业人员对早产儿管理的可用性。方法:向608个新生儿结局评估国际网络(iNeo)的新生儿重症监护病房分发问卷。网络包括:澳大利亚/新西兰(n= 30)、巴西(n=20)、加拿大(n=32)、芬兰(n=5)、法国(n=70)、以色列(n=26)、日本(n=292)、波兰(n=56)、西班牙(n=55)、瑞典(n=9)、瑞士(n=9)和托斯卡纳(n=4)。问题集中在2023年医生、护士和其他医疗专业人员的可用性上。结果:382例(63%)新生儿重症监护病房有应答。医疗保健专业人员的24/7可用性在网络内部和网络之间各不相同,据报道,总体而言,新生儿科医生为66%,新生儿研究员为55%,儿科住院医师为62%,执业护士为55%。护士与患者的比例在复杂重症监护婴儿中最常见的是1:1(53%)和1:2重症监护婴儿(48%)。据报道,呼吸治疗师和药剂师的24/7可用性较低。结论:医护人员的可获得性存在显著差异,这可能与新生儿重症监护病房的组织和管理有关
{"title":"Healthcare professionals' availability for management of preterm neonates < 29 weeks' gestation in 12 iNeo neonatal networks.","authors":"Gil Klinger, Maher Shahroor, Dan Felder, Kei Lui, Annalisa Mori, Mark Adams, Laura San Feliciano, Tetsuya Isayama, Valerie Biran, Dirk Bassler, Brian Reichman, Aleksandra Skubisz, Malcolm Battin, Liisa Lehtonen, Kjell Helenius, Maximo Vento, Satoshi Kusuda, Mikael Norman, Renato S Procianoy, Neha Goswami, Prakesh S Shah","doi":"10.1159/000551461","DOIUrl":"10.1159/000551461","url":null,"abstract":"<p><strong>Introduction: </strong>Availability and expertise of healthcare professional are essential for the quality of care of preterm infants. Objective was to survey different healthcare professionals' availability for management of preterm neonates <29 weeks' gestation among neonatal intensive care units (NICU) of 12 population-based neonatal networks.</p><p><strong>Methods: </strong>Questionnaires were distributed to 608 NICU participating in the International Network for Evaluating Outcomes in Neonates (iNeo). Networks included: Australia/New-Zealand (n= 30), Brazil (n=20), Canada (n=32), Finland (n=5), France (n=70), Israel (n=26), Japan (n=292), Poland (n=56), Spain (n=55), Sweden (n=9), Switzerland (n=9) and Tuscany (n=4). Questions focused on availability of physicians, nurses and additional healthcare professionals in 2023.</p><p><strong>Results: </strong>A total of 382 (63%) NICU responded. The 24/7 availability of healthcare professionals varied within and between networks and overall was reported to be 66% for neonatologists, 55% for neonatal fellows, 62% for pediatric residents and 55% for nurse practitioners. Nurse-to-patient ratios were most commonly 1:1 for complex critical care infants (53%) and 1:2 for intensive care infants (48%). Low 24/7 availability was reported for respiratory therapists and pharmacists.</p><p><strong>Conclusions: </strong>Marked variations exist in health care professionals' availability, which might be associated with NICU organization and management of infants <29 weeks' gestation. While majority of NICU have reported 24/7 availability of neonatologists, the availability of other healthcare professionals was inconsistent. Nurse-to-patient ratio has improved. Further evaluation is needed to understand how these variations are associated with outcomes of extremely preterm infants and to optimize resource utilization.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-17"},"PeriodicalIF":3.0,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2025. 欧洲呼吸窘迫综合征管理共识指南- 2025。
IF 3 Pub Date : 2026-03-09 DOI: 10.1159/000551062
David G Sweet, Virgilio P Carnielli, Gorm Greisen, Mikko Hallman, Katrin Klebermass-Schrehof, Anna Lavizzari, Eren Ozek, Arjan Te Pas, Charles C Roehr, Ola D Saugstad, Umberto Simeoni, Maximo Vento, Gerry H A Visser, Christian P Speer

Every year new evidence emerges about how best to care for babies with respiratory distress. We report the seventh version of "European Guidelines for the Management of RDS" by a panel of European neonatologists and a perinatal obstetrician based on available literature up to mid-2025. Optimising outcome involves collaboration with obstetricians to predict risk of preterm delivery, consideration of transfer to perinatal centres and perinatal optimisation including antenatal steroids. Delivery room protocols should include maintenance of normal body temperature whilst aiming to promote spontaneous breathing before clamping the umbilical cord, using non-invasive respiratory support where possible and considering early use of surfactant via thin catheter in an attempt to avoid intubation. Ongoing non-invasive respiratory support and judicious use of surfactant will improve outcomes. If mechanical ventilation is needed, lung protective strategies should be employed and ventilation continued for the shortest time possible to reduce risk of bronchopulmonary dysplasia. Protocols for supportive care are also reviewed. What is New? Prenatal management remains largely unchanged, perhaps with more emphasis on confirming preterm labour, to allow more judicious use of antenatal steroids. In the delivery room we suggest physiological based cord clamping rather than time based, with an emphasis on strategies for managing thermal care if equipment is available before the cord is cut. Starting FiO2 of 0.6 rather than 0.3 at birth should reduce bradycardia and need for chest compressions and adrenaline for infants born < 29 weeks' gestational age. Surfactant prophylaxis has reappeared for extremely preterm infants in the current era of Less Invasive Surfactant Administration (LISA), with an emphasis on use of videolaryngoscopy for LISA catheter placement or intubation because of greater first pass success for intubations. Nasal ventilation rather than CPAP now seems the most potent mode of non-invasive respiratory support, both after initial stabilisation and when coming off mechanical ventilation, although there is no unified approach as to how best to provide it. For babies who have not received prophylactic surfactant, the treatment thresholds of FiO2 0.3 are unchanged, but with more emphasis on using ultrasound where possible to diagnose RDS regardless of FiO2 requirements in babies with signs of respiratory distress.

每年都有新的证据表明如何最好地照顾患有呼吸窘迫的婴儿。我们报告了第七版“欧洲RDS管理指南”,由欧洲新生儿学家和围产期产科医生组成的小组基于2025年中期的现有文献。优化结果包括与产科医生合作预测早产风险,考虑转移到围产期中心和围产期优化,包括产前类固醇。产房方案应包括维持正常体温,同时在夹紧脐带前促进自主呼吸,在可能的情况下使用无创呼吸支持,并考虑通过薄导管早期使用表面活性剂,以避免插管。持续的无创呼吸支持和明智的使用表面活性剂将改善预后。如果需要机械通气,应采取肺保护策略,尽可能短时间持续通气,以降低支气管肺发育不良的风险。支持治疗方案也进行了审查。有什么新鲜事吗?产前管理基本上保持不变,可能更强调确认早产,以便更明智地使用产前类固醇。在产房,我们建议基于生理的脐带夹紧,而不是基于时间,重点是管理热护理的策略,如果设备在脐带被切断之前可用。对于小于29周胎龄的婴儿,在出生时开始FiO2为0.6而不是0.3应该减少心动过缓和胸外按压和肾上腺素的需要。在目前微创表面活性剂给药(LISA)的时代,表面活性剂预防已经重新出现在极早产儿中,重点是使用视频喉镜进行LISA导管放置或插管,因为插管的第一次通过成功率更高。鼻通气而不是CPAP现在似乎是最有效的无创呼吸支持模式,无论是在初始稳定后还是在脱离机械通气时,尽管没有统一的方法来最好地提供它。对于未接受预防性表面活性剂治疗的婴儿,FiO2 0.3的治疗阈值不变,但对于有呼吸窘迫迹象的婴儿,更强调在可能的情况下使用超声诊断RDS,而不考虑FiO2需求。
{"title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2025.","authors":"David G Sweet, Virgilio P Carnielli, Gorm Greisen, Mikko Hallman, Katrin Klebermass-Schrehof, Anna Lavizzari, Eren Ozek, Arjan Te Pas, Charles C Roehr, Ola D Saugstad, Umberto Simeoni, Maximo Vento, Gerry H A Visser, Christian P Speer","doi":"10.1159/000551062","DOIUrl":"https://doi.org/10.1159/000551062","url":null,"abstract":"<p><p>Every year new evidence emerges about how best to care for babies with respiratory distress. We report the seventh version of \"European Guidelines for the Management of RDS\" by a panel of European neonatologists and a perinatal obstetrician based on available literature up to mid-2025. Optimising outcome involves collaboration with obstetricians to predict risk of preterm delivery, consideration of transfer to perinatal centres and perinatal optimisation including antenatal steroids. Delivery room protocols should include maintenance of normal body temperature whilst aiming to promote spontaneous breathing before clamping the umbilical cord, using non-invasive respiratory support where possible and considering early use of surfactant via thin catheter in an attempt to avoid intubation. Ongoing non-invasive respiratory support and judicious use of surfactant will improve outcomes. If mechanical ventilation is needed, lung protective strategies should be employed and ventilation continued for the shortest time possible to reduce risk of bronchopulmonary dysplasia. Protocols for supportive care are also reviewed. What is New? Prenatal management remains largely unchanged, perhaps with more emphasis on confirming preterm labour, to allow more judicious use of antenatal steroids. In the delivery room we suggest physiological based cord clamping rather than time based, with an emphasis on strategies for managing thermal care if equipment is available before the cord is cut. Starting FiO2 of 0.6 rather than 0.3 at birth should reduce bradycardia and need for chest compressions and adrenaline for infants born < 29 weeks' gestational age. Surfactant prophylaxis has reappeared for extremely preterm infants in the current era of Less Invasive Surfactant Administration (LISA), with an emphasis on use of videolaryngoscopy for LISA catheter placement or intubation because of greater first pass success for intubations. Nasal ventilation rather than CPAP now seems the most potent mode of non-invasive respiratory support, both after initial stabilisation and when coming off mechanical ventilation, although there is no unified approach as to how best to provide it. For babies who have not received prophylactic surfactant, the treatment thresholds of FiO2 0.3 are unchanged, but with more emphasis on using ultrasound where possible to diagnose RDS regardless of FiO2 requirements in babies with signs of respiratory distress.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1-40"},"PeriodicalIF":3.0,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neonatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1